Month: December 2024

LOS ANGELES, Dec. 20, 2024 (GLOBE NEWSWIRE) — Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced that it has received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule, 5550(a)(2). The Company’s security will continue to be listed and traded on The Nasdaq Stock Market and this matter is now closed. Renovaro previously received a notification letter from the Nasdaq Listing Qualifications Department on September 12, 2024, notifying the Company that, over the previous 30 consecutive business days, the closing bid price of the Company’s common stock had been below the minimum of $1.00 per share...

LOS ANGELES, Dec. 20, 2024 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), an award-winning, creator-first, music, entertainment, and technology platform, announced today that the company received a formal written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that LiveOne has regained compliance with Nasdaq’s minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) and that this matter is now closed. LiveOne’s shares of common stock will continue to trade on Nasdaq under the symbol “LVO”. This confirmation follows the Company’s continued efforts to improve its balance sheet by enhancing shareholder value. About LiveOneHeadquartered in Los Angeles, CA, LiveOne (Nasdaq: LVO) is an award-winning, creator-first, music, entertainment, and technology platform focused on delivering premium experiences...

BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for IMCIVREE® (setmelanotide) to include children as young as 2 years old. IMCIVREE is indicated to reduce excess body weight and maintain weight reduction long-term in patients 2 years of age and older with syndromic or monogenic obesity due to Bardet-Biedl syndrome (BBS) or genetically confirmed pro-opiomelanocortin (POMC), including proprotein convertase subtilisin/kexin type 1 (PCSK1), deficiency or leptin receptor (LEPR) deficiency. BBS and POMC, PCSK1 and LEPR deficiencies are rare melanocortin-4 receptor (MC4R)...

Press releaseParis, 20 December 2024 Transactions carried out as part of a share buyback program and outside of a liquidity contract Orange announces that it has purchased treasury shares within the framework of its 2024 share buyback program. These shares have been acquired to honor obligations related to long-term incentive plans for corporate officers and senior employees. The long-term incentive plans, which are conditional on presence and performance, were set up with the aim of involving Group key managers in the success of its strategic plan. Name of the issuer: Orange (LEI: 969500MCOONR8990S771)References of the share buyback program: A description of the program authorized by the Shareholders’ General Meeting held on 22 May 2024 (16th resolution) can be found in Orange’s 2023 universal registration document (section 6.5)Securities...

— Company On Track to Deliver $65 Million Annualized Fixed Cost Reduction — — Company to Maintain Presence in Salt Lake City — MIDVALE, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) — Beyond, Inc. (NYSE:BYON), owner of Bed Bath & Beyond, Overstock, Zulily, and other online retail brands designed to unlock your family’s and home’s potential (“the Company”), today announced that it has completed the transaction with Salt Lake County to sell the Company’s corporate headquarters located in Midvale, Utah on December 20, 2024. The sale of the corporate headquarters aligns with the Company’s strategic plan to reduce debt and fixed costs, free up capital for new growth opportunities, and generate cash flow. “I am pleased to report we have delivered almost 90% of our $65 million annualized fixed cost expense reduction while making sequential...

EDMONTON, Alberta, Dec. 20, 2024 (GLOBE NEWSWIRE) — Capital Power Corporation (TSX: CPX) (“Capital Power”) is pleased to announce the closing today of its previously announced sale of a 49% interest in the Quality Wind facility in British Columbia and the Port Dover and Nanticoke Wind facility in Ontario to Axium Infrastructure (“Axium”). The renewable power asset sell-down transaction was previously announced on November 26, 2024. Total pre-tax cash proceeds to Capital Power from the transaction are expected to be approximately $340 million, inclusive of working capital. Capital Power will remain as operator for the facilities and receive an asset management fee. Territorial AcknowledgementIn the spirit of reconciliation, Capital Power respectfully acknowledges that we operate within the ancestral homelands, traditional...

Beijing, China, Dec. 20, 2024 (GLOBE NEWSWIRE) — Leishen Energy Holding Co., Ltd. (the “Company” or “Leishen Energy”) (Nasdaq: LSE), a China-based provider of clean-energy equipment and integrated solutions for the oil and gas industry, today announced the closing of its initial public offering (the “Offering”) of 1,375,000 ordinary shares (“Shares”) at a public offering price of $4.00 per Share. The Shares began trading on the Nasdaq Capital Market on December 19, 2024, under the ticker symbol “LSE”. The Company received aggregate gross proceeds of $5,500,000 from this Offering, before deducting underwriting discounts and commissions and offering expenses payable by the Company. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 206,250 Shares at the public offering price, less...